{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:52:07Z","timestamp":1791337927487,"version":"4.3.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00953-9","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:25:42Z","timestamp":1791336342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of new ER-targeted anticancer hits active against MCF-7 breast cancer cells in the marine fungal secondary metabolite library using computative and experimental approaches"],"prefix":"10.1007","volume":"40","author":[{"given":"Ekaterina A.","family":"Yurchenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana E.","family":"Nesterenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid A.","family":"Kaluzhskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeniy O.","family":"Yablokov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina A.","family":"Chingizova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina A.","family":"Lesovaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis S.","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry L.","family":"Aminin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton N.","family":"Yurchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"953_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.6987","author":"C Cancer","year":"2022","unstructured":"Global Burden of Disease, Cancer C (2022) Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. https:\/\/doi.org\/10.1001\/jamaoncol.2021.6987","journal-title":"JAMA Oncol"},{"key":"953_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2022.08.010","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S et al (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. https:\/\/doi.org\/10.1016\/j.breast.2022.08.010","journal-title":"Breast"},{"key":"953_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71673","author":"S Iftikhar","year":"2026","unstructured":"Iftikhar S, Burr E, Freigoun A, Nearney T, Kanda CQ, Robinson H, Vermeren C, Wickramaratne U, Everest M, Foley L et al (2026) Male breast cancer: growing insights and continuing challenges. Cancer Med. https:\/\/doi.org\/10.1002\/cam4.71673","journal-title":"Cancer Med"},{"key":"953_CR4","doi-asserted-by":"publisher","unstructured":"Sah AK, Choudhary RK, Sabrievna VA, Dzhuraevich KI, Abbas AM, Shalabi MG, Siddique NA, Alshammari RR, Trivedi N, Elshaikh RH (2026) Male breast cancer: epidemiology, diagnosis, molecular mechanisms, therapeutics, and future prospective. Oncol Res. https:\/\/doi.org\/10.32604\/or.2025.068238","DOI":"10.32604\/or.2025.068238"},{"key":"953_CR5","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.12.4470","author":"E Enmark","year":"1997","unstructured":"Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskj\u00f6ld M, Gustafsson J-Ak (1997) Human estrogen receptor \u03b2-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metabolism. https:\/\/doi.org\/10.1210\/jcem.82.12.4470","journal-title":"J Clin Endocrinol Metabolism"},{"key":"953_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(96)00782-X","author":"S Mosselman","year":"1996","unstructured":"Mosselman S, Polman J, Dijkema R (1996) ER\u03b2: Identification and characterization of a novel human estrogen receptor. FEBS Lett. https:\/\/doi.org\/10.1016\/0014-5793(96)00782-X. https:\/\/doi.org\/","journal-title":"FEBS Lett"},{"key":"953_CR7","doi-asserted-by":"crossref","unstructured":"Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstr\u00f6m O, \u00d6hman L, Greene GL, Gustafsson J-\u00c5, Carlquist M (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature","DOI":"10.1038\/39645"},{"key":"953_CR8","doi-asserted-by":"crossref","unstructured":"Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstr\u00f6m O, Ljunggren J, Gustafsson J\u00c5, Carlquist M (1999) Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J","DOI":"10.1093\/emboj\/18.17.4608"},{"key":"953_CR9","unstructured":"Osborne CK, Schiff R, Fuqua SA, Shou J (2001) Estrogen receptor: current understanding of its activation and modulation. Clin. Cancer Res."},{"key":"953_CR10","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2001.81.4.1535","author":"S Nilsson","year":"2001","unstructured":"Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson Gr, Enmark E, Pettersson K, Warner M, Gustafsson J-\u00c5 (2001) Mechanisms of estrogen action. Physiol Rev. https:\/\/doi.org\/10.1152\/physrev.2001.81.4.1535","journal-title":"Physiol Rev"},{"key":"953_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076834","author":"L Clusan","year":"2023","unstructured":"Clusan L, Ferri\u00e8re F, Flouriot G, Pakdel F (2023) A basic review on estrogen receptor signaling pathways in breast cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24076834","journal-title":"Int J Mol Sci"},{"key":"953_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103861","author":"M Pagliuca","year":"2022","unstructured":"Pagliuca M, Donato M, D\u2019Amato AL, Rosanova M, Russo AOM, Scafetta R, De Angelis C, Trivedi MV, Andr\u00e9 F, Arpino G et al (2022) New steps on an old path: novel estrogen receptor inhibitors in breast cancer. Crit Rev Oncol\/Hematol. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103861","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"953_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/receptors3020010","author":"H Nagandla","year":"2024","unstructured":"Nagandla H, Thomas C (2024) Estrogen signals through ER\u03b2 in breast cancer; what we have learned since the discovery of the receptor. Receptors. https:\/\/doi.org\/10.3390\/receptors3020010","journal-title":"Receptors"},{"key":"953_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2015.04.008","author":"M Jia","year":"2015","unstructured":"Jia M, Dahlman-Wright K, Gustafsson J-\u00c5 (2015) Estrogen receptor alpha and beta in health and disease. Best Pract Res Clin Endocrinol Metab. https:\/\/doi.org\/10.1016\/j.beem.2015.04.008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"953_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2024.106522","author":"JC Valent\u00edn L\u00f3pez","year":"2024","unstructured":"Valent\u00edn L\u00f3pez JC, Lange CA, Dehm SM (2024) Androgen receptor and estrogen receptor variants in prostate and breast cancers. J Steroid Biochem Mol Biol. https:\/\/doi.org\/10.1016\/j.jsbmb.2024.106522","journal-title":"J Steroid Biochem Mol Biol"},{"key":"953_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1448687","author":"Y Gao","year":"2024","unstructured":"Gao Y, Yu Y, Zhang M, Yu W, Kang L (2024) Mechanisms of endocrine resistance in hormone receptor-positive breast cancer. Front Oncol. https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/https:\/\/doi.org\/10.3389\/fonc.2024.1448687","journal-title":"Front Oncol"},{"key":"953_CR17","doi-asserted-by":"publisher","unstructured":"Katzenellenbogen BS, Katzenellenbogen JA, Mordecai D (1979) Zearalenones: characterization of the estrogenic potencies and receptor interactions of a series of Fungal \u03b2-resorcylic acid lactones*. Endocrinology. https:\/\/doi.org\/10.1210\/endo-105-1-33","DOI":"10.1210\/endo-105-1-33"},{"key":"953_CR18","doi-asserted-by":"publisher","DOI":"10.1039\/C9MD00570F","author":"I Shagufta; Ahmad","year":"2020","unstructured":"Shagufta; Ahmad I, Mathew S, Rahman S (2020) Recent progress in selective estrogen receptor downregulators (SERDs) for the treatment of breast cancer. RSC Med Chem. https:\/\/doi.org\/10.1039\/C9MD00570F","journal-title":"RSC Med Chem"},{"key":"953_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2024.106632","author":"Z Gui","year":"2025","unstructured":"Gui Z, Shi W, Zhou F, Yan Y, Li Y, Xu Y (2025) The role of estrogen receptors in intracellular estrogen signaling pathways, an overview. J Steroid Biochem Mol Biol. https:\/\/doi.org\/10.1016\/j.jsbmb.2024.106632","journal-title":"J Steroid Biochem Mol Biol"},{"key":"953_CR20","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00913","author":"Y Lu","year":"2020","unstructured":"Lu Y, Liu W (2020) Selective estrogen receptor degraders (SERDs): a promising strategy for estrogen receptor positive endocrine-resistant breast cancer. J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00913","journal-title":"J Med Chem"},{"key":"953_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2014.03.007","author":"J Wang","year":"2014","unstructured":"Wang J, Hu F, Luo Y, Luo H, Huang N, Cheng F, Deng Z, Deng W, Zou K (2014) Estrogenic and anti-estrogenic activities of hispolon from Phellinus lonicerinus (Bond.) Bond. et sing. Fitoterapia. https:\/\/doi.org\/10.1016\/j.fitote.2014.03.007","journal-title":"Fitoterapia"},{"key":"953_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.04.053","author":"W Lim","year":"2015","unstructured":"Lim W, Park J, Lee YH, Hong J, Lee Y (2015) Subglutinol A, an immunosuppressive \u03b1-pyrone diterpenoid from Fusarium subglutinans, acts as an estrogen receptor antagonist. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2015.04.053","journal-title":"Biochem Biophys Res Commun"},{"key":"953_CR23","doi-asserted-by":"publisher","DOI":"10.1039\/d1np00051a","author":"TM Voser","year":"2022","unstructured":"Voser TM, Campbell MD, Carroll AR (2022) How different are marine microbial natural products compared to their terrestrial counterparts? Nat. Prod Rep. https:\/\/doi.org\/10.1039\/d1np00051a","journal-title":"Prod Rep"},{"key":"953_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/md20010062","author":"L-A Giddings","year":"2022","unstructured":"Giddings L-A, Newman DJ (2022) Extremophilic fungi from marine environments: underexplored sources of antitumor, anti-infective and other biologically active agents. Mar Drugs. https:\/\/doi.org\/10.3390\/md20010062","journal-title":"Mar Drugs"},{"key":"953_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbr.2023.100355","author":"P Kumar","year":"2024","unstructured":"Kumar P, Sharma A, Bamrah GK, Choi K-Y (2024) Novel fungal diversity: a new prospect for the commercial production of future anti-cancer compounds. Fungal Biol Rev https:\/\/doi.org\/10.1016\/j.fbr.2023.100355","journal-title":"Fungal Biology Reviews"},{"key":"953_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/md23090353","author":"OO Khmel","year":"2025","unstructured":"Khmel OO, Yurchenko AN, Trinh PTH, Ngoc NTD, Trang VTD, Khanh HHN, Antonov AS, Drozdov KA, Popov RS, Kim NY (2025) Secondary metabolites of the marine sponge-derived fungus Aspergillus subramanianii 1901NT-1.40. 2 and their antimicrobial and anticancer activities. Mar Drugs. https:\/\/doi.org\/10.3390\/md23090353","journal-title":"Mar Drugs"},{"key":"953_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/md22070317","author":"EV Leshchenko","year":"2024","unstructured":"Leshchenko EV, Chingizova EA, Antonov AS, Shlyk NP, Borkunov GV, Berdyshev DV, Chausova VE, Kirichuk NN, Khudyakova YV, Chingizov AR et al (2024) New zosteropenillines and pallidopenillines from the seagrass-derived fungus Penicillium yezoense KMM 4679. Mar Drugs. https:\/\/doi.org\/10.3390\/md22070317","journal-title":"Mar Drugs"},{"key":"953_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/md23100399","author":"EM Zhidkova","year":"2025","unstructured":"Zhidkova EM, Savina ED, Yurchenko EA, Lesovaya EA (2025) Marine-derived steroids for cancer treatment: search for potential selective glucocorticoid receptor agonists\/modulators (SEGRAMs). Mar Drugs. https:\/\/doi.org\/10.3390\/md23100399","journal-title":"Mar Drugs"},{"key":"953_CR29","doi-asserted-by":"publisher","DOI":"10.1039\/C8RA10182E","author":"DS Karlov","year":"2019","unstructured":"Karlov DS, Sosnin S, Tetko IV, Fedorov MV (2019) Chemical space exploration guided by deep neural networks. RSC Adv. https:\/\/doi.org\/10.1039\/C8RA10182E","journal-title":"RSC Adv"},{"key":"953_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112882","author":"A Mauri","year":"2022","unstructured":"Mauri A, Bertola M (2022) Alvascience: a new software suite for the QSAR workflow applied to the blood\u2013brain barrier permeability. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232112882","journal-title":"Int J Mol Sci"},{"key":"953_CR31","doi-asserted-by":"publisher","unstructured":"Huang K, Zhang S, Wang H, Qu Y, Lu Y, Li R, Roohani Y, Qiu L, Cao S, Li G et al Autonomous biomedical research with an artificial intelligence agent. Science. https:\/\/doi.org\/10.1126\/science.adz4351","DOI":"10.1126\/science.adz4351"},{"key":"953_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/0263-7855(84)80060-0","author":"S Anderson","year":"1984","unstructured":"Anderson S (1984) Graphical representation of molecules and substructure-search queries in MACCStm. J Mol Graph. https:\/\/doi.org\/10.1016\/0263-7855(84)80060-0. https:\/\/doi.org\/","journal-title":"J Mol Graph"},{"key":"953_CR33","doi-asserted-by":"publisher","DOI":"10.1021\/ci010132r","author":"JL Durant","year":"2002","unstructured":"Durant JL, Leland BA, Henry DR, Nourse JG (2002) Reoptimization of MDL keys for use in drug discovery. J Chem Inf Comput Sci. https:\/\/doi.org\/10.1021\/ci010132r","journal-title":"J Chem Inf Comput Sci"},{"key":"953_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae236","author":"L Fu","year":"2024","unstructured":"Fu L, Shi S, Yi J, Wang N, He Y, Wu Z, Peng J, Deng Y, Wang W, Wu C et al (2024) ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkae236","journal-title":"Nucleic Acids Res"},{"key":"953_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29081826","author":"DO Shkil","year":"2024","unstructured":"Shkil DO, Muhamedzhanova AA, Petrov PI, Skorb EV, Aliev TA, Steshin IS, Tumanov AV, Kislinskiy AS, Fedorov MV (2024) Expanding predictive capacities in toxicology: insights from hackathon-enhanced data and model aggregation. Molecules. https:\/\/doi.org\/10.3390\/molecules29081826","journal-title":"Molecules"},{"key":"953_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-016-9915-2","author":"Z-J Yao","year":"2016","unstructured":"Yao Z-J, Dong J, Che Y-J, Zhu M-F, Wen M, Wang N-N, Wang S, Lu A-P, Cao D-S (2016) TargetNet: a web service for predicting potential drug\u2013target interaction profiling via multi-target SAR models. J Comput Aided Mol Des. https:\/\/doi.org\/10.1007\/s10822-016-9915-2","journal-title":"J Comput Aided Mol Des"},{"key":"953_CR37","doi-asserted-by":"publisher","DOI":"10.1021\/np9904004","author":"SS Afiyatullov","year":"2000","unstructured":"Afiyatullov SS, Kuznetsova TA, Isakov VV, Pivkin MV, Prokofeva NG, Elyakov GB (2000) New diterpenic altrosides of the fungus Acremonium striatisporum isolated from a sea cucumber. J Nat Prod. https:\/\/doi.org\/10.1021\/np9904004","journal-title":"J Nat Prod"},{"key":"953_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/md21110584","author":"AN Yurchenko","year":"2023","unstructured":"Yurchenko AN, Zhuravleva OI, Khmel OO, Oleynikova GK, Antonov AS, Kirichuk NN, Chausova VE, Kalinovsky AI, Berdyshev DV, Kim NY et al (2023) New cyclopiane diterpenes and polyketide derivatives from marine sediment-derived fungus Penicillium antarcticum KMM 4670 and their biological activities. Mar Drugs. https:\/\/doi.org\/10.3390\/md21110584","journal-title":"Mar Drugs"},{"key":"953_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242316568","author":"EV Leshchenko","year":"2023","unstructured":"Leshchenko EV, Berdyshev DV, Yurchenko EA, Antonov AS, Borkunov GV, Kirichuk NN, Chausova VE, Kalinovskiy AI, Popov RS, Khudyakova YV et al (2023) Bioactive polyketides from the natural complex of the sea urchin-associated fungi Penicillium sajarovii KMM 4718 and Aspergillus protuberus KMM 4747. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms242316568","journal-title":"Int J Mol Sci"},{"key":"953_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2026.02.019","author":"L Kaluzhskiy","year":"2026","unstructured":"Kaluzhskiy L, Yablokov E, Varaksa T, Grudo A, Karputs A, Grabovec I, Mezentsev Y, Zelepuga E, Gnedenko O, Tolkanov D et al (2026) Diverse ligands for mycobacterial CYP124 identified from plant and marine compounds. Biochimie. https:\/\/doi.org\/10.1016\/j.biochi.2026.02.019","journal-title":"Biochimie"},{"key":"953_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)43537-0","author":"SC Brooks","year":"1973","unstructured":"Brooks SC, Locke ER, Soule HD (1973) Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem. https:\/\/doi.org\/10.1016\/S0021-9258(19)43537-0","journal-title":"J Biol Chem"},{"key":"953_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv073","author":"AV Lee","year":"2015","unstructured":"Lee AV, Oesterreich S, Davidson NE (2015) MCF-7 cells\u2014changing the course of breast cancer research and care for 45 years. JNCI: J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv073","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"953_CR43","doi-asserted-by":"publisher","DOI":"10.1021\/jm0209230","author":"V Lubczyk","year":"2002","unstructured":"Lubczyk V, Bachmann H, Gust R (2002) Investigations on estrogen receptor binding. The estrogenic, antiestrogenic, and cytotoxic properties of C2-Alkyl-substituted 1,1-Bis(4-hydroxyphenyl)-2-phenylethenes. J Med Chem. https:\/\/doi.org\/10.1021\/jm0209230","journal-title":"J Med Chem"},{"key":"953_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio775","author":"CG Bologa","year":"2006","unstructured":"Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, Parker MA, Tkachenko SE, Savchuck NP, Sklar LA et al (2006) Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol. https:\/\/doi.org\/10.1038\/nchembio775","journal-title":"Nat Chem Biol"},{"key":"953_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.168","author":"MK Dennis","year":"2009","unstructured":"Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leitao A, Brailoiu E, Deliu E et al (2009) In vivo effects of a GPR30 antagonist. Nat Chem Biol. https:\/\/doi.org\/10.1038\/nchembio.168","journal-title":"Nat Chem Biol"},{"key":"953_CR46","doi-asserted-by":"publisher","DOI":"10.1021\/ci0504723","author":"T Kogej","year":"2006","unstructured":"Kogej T, Engkvist O, Blomberg N, Muresan S (2006) Multifingerprint based similarity searches for targeted class compound selection. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci0504723","journal-title":"J Chem Inf Model"},{"key":"953_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124193","author":"D Bafna","year":"2020","unstructured":"Bafna D, Ban F, Rennie PS, Singh K, Cherkasov A (2020) Computer-aided ligand discovery for estrogen receptor alpha. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21124193","journal-title":"Int J Mol Sci"},{"key":"953_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-2333(01)00048-0","author":"E Schmitt","year":"2001","unstructured":"Schmitt E, Dekant W, Stopper H (2001) Assaying the estrogenicity of phytoestrogens in cells of different estrogen sensitive tissues. Toxicol In Vitro. https:\/\/doi.org\/10.1016\/S0887-2333(01)00048-0","journal-title":"Toxicol In Vitro"},{"key":"953_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06034-2","author":"W Huang","year":"2018","unstructured":"Huang W, Peng Y, Kiselar J, Zhao X, Albaqami A, Mendez D, Chen Y, Chakravarthy S, Gupta S, Ralston C et al (2018) Multidomain architecture of estrogen receptor reveals interfacial cross-talk between its DNA-binding and ligand-binding domains. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-018-06034-2","journal-title":"Nat Comm"},{"key":"953_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0312276","author":"X Liu","year":"2024","unstructured":"Liu X, Matsuyama Y, Sugiyama M, Suyama K, Nose T, Shimohigashi M, Shimohigashi Y (2024) The N-terminal activation function AF-1 domain of ER\u03b1 interacts directly with the C-terminal AF-2-holding ligand-binding domain to recruit the coactivator proteins. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0312276","journal-title":"PLoS ONE"},{"key":"953_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/metabo9100197","author":"V Gonz\u00e1lez-Men\u00e9ndez","year":"2019","unstructured":"Gonz\u00e1lez-Men\u00e9ndez V, Crespo G, Toro C, Mart\u00edn J, de Pedro N, Tormo JR, Genilloud O (2019) Extending the metabolite diversity of the endophyte Dimorphosporicola tragani. Metabolites. https:\/\/doi.org\/10.3390\/metabo9100197","journal-title":"Metabolites"},{"key":"953_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s10600-016-1601-z","author":"OI Zhuravleva","year":"2016","unstructured":"Zhuravleva OI, Kirichuk NN, Denisenko VA, Dmitrenok PS, Yurchenko EA, Min\u2032ko EM, Ivanets EV, Afiyatullov SS (2016) New diorcinol j produced by co-cultivation of marine fungi Aspergillus sulphureus and Isaria felina. Chem Nat Compd. https:\/\/doi.org\/10.1007\/s10600-016-1601-z","journal-title":"Chem Nat Compd"},{"key":"953_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s10600-013-0544-x","author":"AN Yurchenko","year":"2013","unstructured":"Yurchenko AN, Smetanina OF, Khudyakova YV, Kirichuk NN, Yurchenko EA, Afiyatullov SS (2013) Metabolites of the marine isolate of the fungus Curvularia inaequalis. Chem Nat Compd. https:\/\/doi.org\/10.1007\/s10600-013-0544-x","journal-title":"Chem Nat Compd"},{"key":"953_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098150","author":"EV Girich","year":"2023","unstructured":"Girich EV, Trinh PT, Nesterenko LE, Popov RS, Kim NY, Rasin AB, Menchinskaya ES, Kuzmich AS, Chingizova EA, Minin AS et al (2023) Absolute stereochemistry and cytotoxic effects of vismione E from marine sponge-derived fungus Aspergillus sp. 1901NT-1.2.2. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24098150","journal-title":"Int J Mol Sci"},{"key":"953_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2017.08.036","author":"S Stypu\u0142a-Tr\u0119bas","year":"2017","unstructured":"Stypu\u0142a-Tr\u0119bas S, Minta M, Radko L, Jedziniak P, Posyniak A (2017) Nonsteroidal mycotoxin alternariol is a full androgen agonist in the yeast reporter androgen bioassay. Environ Toxico l Pharmacol. https:\/\/doi.org\/10.1016\/j.etap.2017.08.036","journal-title":"Environ Toxico l Pharmacol"},{"key":"953_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2005.08.013","author":"L Lehmann","year":"2006","unstructured":"Lehmann L, Wagner J, Metzler M (2006) Estrogenic and clastogenic potential of the mycotoxin alternariol in cultured mammalian cells. Food Chem Toxicol. https:\/\/doi.org\/10.1016\/j.fct.2005.08.013","journal-title":"Food Chem Toxicol"},{"key":"953_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28361","author":"R Khan","year":"2024","unstructured":"Khan R, Anwar F, Ghazali FM (2024) A comprehensive review of mycotoxins: toxicology, detection, and effective mitigation approaches. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28361","journal-title":"Heliyon"},{"key":"953_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s13659-024-00459-7","author":"SS Starnovskaya","year":"2024","unstructured":"Starnovskaya SS, Nesterenko LE, Popov RS, Kirichuk NN, Chausova VE, Chingizova EA, Chingizov AR, Isaeva MP, Yurchenko EA, Yurchenko AN (2024) Metabolite profiles of Paragliomastix luzulae (formerly named as Acremonium striatisporum) KMM 4401 and its co-cultures with Penicillium hispanicum KMM 4689. Nat Prod Bioprospecting. https:\/\/doi.org\/10.1007\/s13659-024-00459-7","journal-title":"Nat Prod Bioprospecting"},{"key":"953_CR59","doi-asserted-by":"publisher","DOI":"10.1177\/1934578x160110103","author":"X Wang","year":"2016","unstructured":"Wang X, Wedge DE, Cutler SJ (2016) Chemical and biological study of cladosporin, an antimicrobial inhibitor: a review. Nat Prod Commun. https:\/\/doi.org\/10.1177\/1934578x160110103","journal-title":"Nat Prod Commun"},{"key":"953_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22038-x","author":"S Anandan","year":"2022","unstructured":"Anandan S, Gowtham HG, Shivakumara CS, Thampy A, Singh SB, Murali M, Shivamallu C, Pradeep S, Shilpa N, Shati AA et al (2022) Integrated approach for studying bioactive compounds from Cladosporium spp. against estrogen receptor alpha as breast cancer drug target. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-22038-x","journal-title":"Sci Rep"},{"key":"953_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/md15020046","author":"SS Afiyatullov","year":"2017","unstructured":"Afiyatullov SS, Leshchenko EV, Berdyshev DV, Sobolevskaya MP, Antonov AS, Denisenko VA, Popov RS, Pivkin MV, Udovenko AA, Pislyagin EA et al (2017) Zosteropenillines: polyketides from the marine-derived fungus Penicillium thomii. Mar Drugs. https:\/\/doi.org\/10.3390\/md15020046","journal-title":"Mar Drugs"},{"key":"953_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27207034","author":"P Aris","year":"2022","unstructured":"Aris P, Wei Y, Mohamadzadeh M, Xia X (2022) Griseofulvin: an updated overview of old and current knowledge. Molecules. https:\/\/doi.org\/10.3390\/molecules27207034","journal-title":"Molecules"},{"key":"953_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-213","author":"K Rathinasamy","year":"2010","unstructured":"Rathinasamy K, Jindal B, Asthana J, Singh P, Balaji PV, Panda D (2010) Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine. BMC Cancer. https:\/\/doi.org\/10.1186\/1471-2407-10-213","journal-title":"BMC Cancer"},{"key":"953_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1459539","author":"N Yu","year":"2024","unstructured":"Yu N, Fu Y, Fan Q, Lin L, Ning Z, Leng D, Hu M, She T (2024) Antitumor properties of griseofulvin and its toxicity. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1459539","journal-title":"Front Pharmacol"},{"key":"953_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-01207-x","author":"EV Sazonova","year":"2022","unstructured":"Sazonova EV, Chesnokov MS, Zhivotovsky B, Kopeina GS (2022) Drug toxicity assessment: cell proliferation versus cell death. Cell Death Discovery. https:\/\/doi.org\/10.1038\/s41420-022-01207-x","journal-title":"Cell Death Discovery"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00953-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00953-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00953-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:25:43Z","timestamp":1791336343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00953-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["953"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00953-9","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"17 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"248"}}